Managing Patients with CDK 4/6 Inhibitor-Resistance

Dr Hanna drives a discussion regarding breast cancer treatments that have developed resistance to CDK 4/6 inhibitors.

Related Keywords

Samyukta Mullangi ,Sarah Sammons ,Kevin Kalinsky ,Kirolloss Hanna , ,Financial Toxicity ,Time Toxicity ,Oral Prescription ,Insurance ,Patient Navigation ,Cdk 4 6 Inhibitor ,Copay Assistance ,